Anfernee Simons to Detroit

[BlazersBroncos]

Still - a rebuild team like DET, and PDX if in the same position, should always gamble on a guy returning from this type of issue given his potential than move him for someone as pedestrian and one dimensional as Simons.

If Shadeon Sharpe had the same blood clot issue would you trade him for Tyler Herro?

[Walton1one]

Is Shaeden Sharpe even going to be as good as Tyler Herro?

Seriously, Sharpe oozes talent, but can't stay on the court...

Also, I'd value Sharpe + shoulder injuries over of Ausar + his blood clot issue

[BlazersBroncos]

Is Shaeden Sharpe even going to be as good as Tyler Herro?

Seriously, Sharpe oozes talent, but can't stay on the court...

Also, I'd value Sharpe + shoulder injuries over of Ausar + his blood clot issue

I am just saying as a rebuild team, like PDX and DET are, would you rather gamble on the youngster with a blood clot issue or take on a 25 year old signed to a big deal who has not shown much outside shooting / scoring and plays a non-premium position w/o elite size (IE if Simons or Herro were 6'8 with their limited skillset I would argue that would change this theoretical question).

If reversed, and Sharpe had blood clots, would you trade him for Tyler Herro? Obvious answer for PDX fans is a resounding NO. We should expect DET, a franchise in a similar position, to return the same answer.

Simons is only appealing to DET if he is super cheap to obtain - and even that argument is dwindling quickly as Ivey shows out a bit.

[Walton1one]

Well

Is Shaeden Sharpe even going to be as good as Tyler Herro?

Seriously, Sharpe oozes talent, but can't stay on the court...

Also, I'd value Sharpe + shoulder injuries over of Ausar + his blood clot issue

I am just saying as a rebuild team, like PDX and DET are, would you rather gamble on the youngster with a blood clot issue or take on a 25 year old signed to a big deal who has not shown much outside shooting / scoring and plays a non-premium position w/o elite size (IE if Simons or Herro were 6'8 with their limited skillset I would argue that would change this theoretical question).

If reversed, and Sharpe had blood clots, would you trade him for Tyler Herro? Obvious answer for PDX fans is a resounding NO. We should expect DET, a franchise in a similar position, to return the same answer.

Simons is only appealing to DET if he is super cheap to obtain - and even that argument is dwindling quickly as Ivey shows out a bit.

I would say this.

- Simons is not old, he is only 25, Cade Cunningham is 23, so he would fit nicely in the backcourt with him.
- Simons complements Cunningham nicely and offers a skill (shooting) that DET is lacking
- DET has been rebuilding for 5? years now, impressions are they want to start winning, Simons would be a step in the right direction FOR THEM
- Simons does not fit with POR b\c they have Scoot Henderson, whom he is blocking, and the two do not fit well together in the backcourt. Simons would not impact Cunningham in that way, he would slot in nicely as the SG.
- Simons' deal is for 2 more years, and judging by recent signings, he is mildly overpaid ($2-4mil)
- DET roster, athletic wings\bigs, big PG, complement Simons' skillset & offset his deficiencies much better than POR roster does
- DET is not giving up a 1st round pick here, but instead a player in Thompson (whom they just drafted a similar player\Holland), who may or may not be even able to play and if he is, who knows in what capacity\how long?

Hard to judge a Sharpe\Herro situation, b\c POR is not DET, nor does POR roster composition match that of DET. POR has Scoot, DET has Cunningham, BIG difference

Quite frankly, the more I read about Ausar situation the less I would be inclined to want to trade for him. Hope he comes back healthy and able to play a long career, but blood clot issues are not good for longevity in the NBA.

Christian Koloko
The Los Angeles Lakers center was medically cleared to play in October 2024 after a blood clot issue threatened his career. Koloko was waived by the Toronto Raptors in January 2024 and signed with the Lakers in the offseason.

Ausar Thompson
The Detroit Pistons small forward suffered a season-ending blood clot during his rookie year. Thompson was cleared for non-contact drills and conditioning, but he doesn't know when he'll be fully cleared for training camp.

Chris Bosh
The Hall of Famer's career was ended by blood clots. A clot in his lung in 2014-15 forced him to sit out the rest of the season, and a clot in his leg in 2015-16 ended his season for good.

Mirza Teletovic
The former NBA forward was diagnosed with multiple blood clots in his lungs in 2017. He returned to the court in April, but his blood clots returned in December and he was waived by the Milwaukee Bucks in March 2018.

[BlazersBroncos]

DET has Ivey who they invested a premium pick on to be the back court mate with Cade and who is starting the season strong. He also is due to be paid sooner than later. You left that part out.

DET would end up in a similar situation with 2 former top 10 picks at guard and Simon’s - basically where PDX is at right now.

You’re a great poster but I think your way off on this one.

[wadenation305]

Is Shaeden Sharpe even going to be as good as Tyler Herro?

Seriously, Sharpe oozes talent, but can't stay on the court...

Also, I'd value Sharpe + shoulder injuries over of Ausar + his blood clot issue

I am just saying as a rebuild team, like PDX and DET are, would you rather gamble on the youngster with a blood clot issue or take on a 25 year old signed to a big deal who has not shown much outside shooting / scoring and plays a non-premium position w/o elite size (IE if Simons or Herro were 6'8 with their limited skillset I would argue that would change this theoretical question).

If reversed, and Sharpe had blood clots, would you trade him for Tyler Herro? Obvious answer for PDX fans is a resounding NO. We should expect DET, a franchise in a similar position, to return the same answer.

Simons is only appealing to DET if he is super cheap to obtain - and even that argument is dwindling quickly as Ivey shows out a bit.

It depends on what team you're asking. If you ask Heat fans, after what happened with Bosh and the subsequent years of massive dead money on the books, we want no part of blood clots.

[Walton1one]

DET has Ivey who they invested a premium pick on to be the back court mate with Cade and who is starting the season strong. He also is due to be paid sooner than later. You left that part out.

DET would end up in a similar situation with 2 former top 10 picks at guard and Simon’s - basically where PDX is at right now.

You’re a great poster but I think your way off on this one.

No worries, agree to disagree. I think we both would like to see Simons moved, hopefully, Cronin does so, and when\if that happens we will know for sure what teams are willing to pay to acquire him. I am hopeful that improved play by Camara\Rupert\Murray\Banton, may make it more likely that he is moved.

[flranger]

Put me in the camp of on that contract Simons is only neutral value. No reason for anyone to add anything to get him.

[Kalamazoo317]

I think the "desperate for shooting" narrative folks have for the Pistons is a last season narrative and ignores that Ivey and Cade are improved shooters and we added Harris, Fontecchio, THJ, and Beasley, all as legit floor spacers. You can always use more shooting, but we can afford to be selective about it.

[Pattycakes]

/thread

We’ll hold out for better value.

[PDXKnight]

Fine by me. It feels like selling low for Portland and a good value for Detroit but I'm so done with ant I'd strongly consider